Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target.

OBJECTIVE The reduction of pain in the course of antiinflammatory therapy can result from an attenuation of the inflammatory process and/or from the neutralization of endogenous mediators of inflammation that act directly on nociceptive neurons. The purpose of this study was to investigate whether analgesic effects of the neutralization of tumor necrosis factor alpha (TNFalpha) are due to an attenuation of inflammation or whether direct neuronal effects significantly contribute to pain relief in the course of therapy. METHODS Locomotor and pain-related behavior and histology were assessed in rats with chronic antigen-induced arthritis (AIA) in the knee joint, and the rats were treated with systemic saline, etanercept, or infliximab. The expression of TNF receptors (TNFRs) in dorsal root ganglia was measured using immunohistochemical analysis and polymerase chain reaction. Action potentials were recorded from afferent Adelta fibers and C fibers of the medial knee joint nerve, and etanercept and infliximab were injected intraarticularly into normal or inflamed knee joints (AIA or kaolin/carrageenan-induced inflammation). RESULTS In rats with AIA, both etanercept and infliximab significantly decreased inflammation-induced locomotor and pain-related behavior, while joint swelling was only weakly attenuated and histomorphology still revealed pronounced inflammation. A large proportion of dorsal root ganglion neurons showed TNFRI- and TNFRII-like immunoreactivity. Intraarticular injection of etanercept reduced the responses of joint afferents to mechanical stimulation of the inflamed joint starting 30 minutes after injection, but had no effect on responses to mechanical stimulation of the uninflamed joint. CONCLUSION Overall, these data show the pronounced antinociceptive effects of TNFalpha neutralization, thus suggesting that reduction of the effects of TNFalpha on pain fibers themselves significantly contributes to pain relief.

[1]  H. Schaible,et al.  The cytokine TNFα increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation , 2007, Molecular and Cellular Neuroscience.

[2]  C. Sommer,et al.  Differences in inflammatory pain in nNOS‐, iNOS‐ and eNOS‐deficient mice , 2007, European journal of pain.

[3]  J. McDougall.  Arthritis and Pain. Neurogenic origin of joint pain , 2006, Arthritis research & therapy.

[4]  H. Schaible,et al.  Pathophysiology and treatment of pain in joint disease. , 2006, Advanced drug delivery reviews.

[5]  P. Villiger,et al.  Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases , 2006, Springer Seminars in Immunopathology.

[6]  Robert W. Gereau,et al.  Acute p38-Mediated Modulation of Tetrodotoxin-Resistant Sodium Channels in Mouse Sensory Neurons by Tumor Necrosis Factor-α , 2006, The Journal of Neuroscience.

[7]  M. Fitzcharles,et al.  Pain: understanding and challenges for the rheumatologist. , 2005, Arthritis and rheumatism.

[8]  J. McDougall,et al.  Inhibitory effect of amiloride and gadolinium on fine afferent nerves in the rat knee: evidence of mechanogated ion channels in joints , 2005, Experimental Brain Research.

[9]  S. Hunt,et al.  The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation , 2005, Arthritis research & therapy.

[10]  M. Chimenti,et al.  Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab. , 2005, Arthritis and rheumatism.

[11]  P. Petrow,et al.  Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis , 2005, Arthritis research & therapy.

[12]  K. Hobbs.  Chronic sarcoid arthritis treated with intraarticular etanercept. , 2005, Arthritis and rheumatism.

[13]  H. Schaible,et al.  The expression and localization of somatostatin receptors in dorsal root ganglion neurons of normal and monoarthritic rats , 2004, Neuroscience.

[14]  H. Lee,et al.  Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model , 2004, Neuroreport.

[15]  K. Olmarker,et al.  Selective Inhibition of Tumor Necrosis Factor-&agr; Prevents Nucleus Pulposus-Induced Histologic Changes in the Dorsal Root Ganglion , 2004, Spine.

[16]  Yanzhang Li,et al.  Cell-Specific Expression and Lipopolysaccharide-Induced Regulation of Tumor Necrosis Factor α (TNFα) and TNF Receptors in Rat Dorsal Root Ganglion , 2004, The Journal of Neuroscience.

[17]  K. Olmarker,et al.  Infliximab Attenuates Immunoreactivity of Brain-derived Neurotrophic Factor in a Rat Model of Herniated Nucleus Pulposus , 2004, Spine.

[18]  C. Sommer,et al.  Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia , 2004, Neuroscience Letters.

[19]  E. Wagner,et al.  Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade. , 2003, Arthritis and rheumatism.

[20]  E. Sternberg,et al.  Neuroendocrine regulation of immunity. , 2003, Annual review of immunology.

[21]  K. Olmarker,et al.  Changes in Spontaneous Behavior in Rats Exposed to Experimental Disc Herniation are Blocked by Selective TNF-Alpha Inhibition , 2003, Spine.

[22]  H. Paulus,et al.  Acute injection site reaction to intraarticular etanercept administration. , 2003, Arthritis and rheumatism.

[23]  J. Smolen,et al.  Therapeutic strategies for rheumatoid arthritis , 2003, Nature Reviews Drug Discovery.

[24]  L. Sorkin,et al.  Increased Sensitivity of Injured and Adjacent Uninjured Rat Primary Sensory Neurons to Exogenous Tumor Necrosis Factor-α after Spinal Nerve Ligation , 2003, The Journal of Neuroscience.

[25]  H. Lorenz,et al.  Perspectives for TNF-α-targeting therapies , 2002, Arthritis research.

[26]  S. M. McFarlane,et al.  TNF-α receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones , 2002, Neuropharmacology.

[27]  C. Geis,et al.  Anterograde Transport of Tumor Necrosis Factor-α in the Intact and Injured Rat Sciatic Nerve , 2002, The Journal of Neuroscience.

[28]  C. Sommer,et al.  Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy , 2001, Brain Research.

[29]  C. Sommer,et al.  Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice , 2001, Neuroscience Letters.

[30]  L. Arendt-Nielsen,et al.  Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study , 2001, Pain.

[31]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[32]  R. Myers,et al.  Axonal transport of TNF-α in painful neuropathy: distribution of ligand tracer and TNF receptors , 2001, Journal of Neuroimmunology.

[33]  M. Kress,et al.  Involvement of the Proinflammatory Cytokines Tumor Necrosis Factor-α, IL-1β, and IL-6 But Not IL-8 in the Development of Heat Hyperalgesia: Effects on Heat-Evoked Calcitonin Gene-Related Peptide Release from Rat Skin , 2000, The Journal of Neuroscience.

[34]  P. Petrow,et al.  Monoarticular antigen-induced arthritis leads to pronounced bilateral upregulation of the expression of neurokinin 1 and bradykinin 2 receptors in dorsal root ganglion neurons of rats , 2000, Arthritis research.

[35]  C. Woolf,et al.  Neuronal plasticity: increasing the gain in pain. , 2000, Science.

[36]  C. Sommer,et al.  Hyperalgesia in Experimental Neuropathy Is Dependent on the TNF Receptor 1 , 1998, Experimental Neurology.

[37]  F. Emmrich,et al.  Induction of flare-up reactions in rat antigen-induced arthritis. , 1995, Journal of autoimmunity.

[38]  S. Maier,et al.  Characterization of cytokine-induced hyperalgesia , 1994, Brain Research.

[39]  H. Schaible,et al.  Afferent and spinal mechanisms of joint pain , 1993, Pain.

[40]  H. Dai,et al.  Methods to Assess the Development and Recovery of Locomotor Function after Spinal Cord Injury in Rats , 1993, Experimental Neurology.

[41]  F. Cunha,et al.  The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia , 1992 .

[42]  S. Ferreira,et al.  Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue , 1988, Nature.

[43]  L. Arendt-Nielsen,et al.  Osteoarthritis and its association with mechanical hyperalgesia , 2008 .

[44]  H. Schaible,et al.  Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. , 2007, Arthritis and rheumatism.

[45]  R. Griffiths.  Characterisation and pharmacological sensitivity of antigen arthritis induced by methylated bovine serum albumin in the rat , 2005, Agents and Actions.

[46]  R. Schmidt,et al.  Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. , 2004, Arthritis and rheumatism.

[47]  M. Feldmann,et al.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.